Kansas City, KS- The discussion focused on advancements in Alzheimer's diagnosis and treatment.
Brian James, diagnosed with mild cognitive impairment and Alzheimer's, plans to take a new blood test that detects elevated levels of proteins associated with the disease. The blood test, which is less invasive and costly than alternatives like amyloid PET scans, can help identify amyloid in the brain, a key indicator of Alzheimer's.
Drs. Russell Swerdlow and Jeff Burns highlighted the importance of early detection, the role of family history, and the impact of lifestyle changes on disease progression.
Additionally, the Cognitive Care Network was discussed as a resource for caregivers, emphasizing the need for community support and addressing the emotional challenges faced by caregivers.
Learn more at: Alzheimer’s Disease Memory Clinic | The University of Kansas Health System
